A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer Videos

PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT - Michael Hofman

Phase 3 CLARIFY Trial Investigates 64Cu-SAR-bisPSMA PET for Improved Prostate Cancer Detection - Louise Emmett

CLARIFY Trial: Advancing Prostate Cancer Imaging with 64Cu-SAR-bisPSMA PET - Neal Shore

PSMA PET in Prostate Cancer: Balancing Sensitivity and Clinical Relevance - Ravi Madan

PSMA-PET/CT Guided Salvage Radiotherapy: Improving Prostate Cancer Outcomes - Constantinos Zamboglou

Patient Selection for PSMA Radioligand Therapy - Ephraim Parent

NCCN Guidelines: A Framework for PET Imaging Integration in Prostate Cancer Care - Edward Schaeffer

OSPREY and CONDOR Trials - Evaluating F-18 DCFPyL PSMA Imaging for Prostate Cancer - Michael J. Morris

The Biology of Prostate Cancer Metastasis and What PSMA Imaging Is Teaching Us: Presentation and Discussion - Kenneth J. Pienta

Diagnostic Molecular Imaging for Prostate Cancer in the United States: A Focus on Lesion Localization and Distribution Using 18F-DCFPyL PET/CT at Biochemical Recurrence Lecture & Discussion - Andrei H. Iagaru

Implications of PSMA PET Imaging for Prostate Cancer Presentation & Discussion - Oliver Sartor

Applying Artificial Intelligence (AI) to PSMA-targeted PET Imaging Agent 18F-DCFPyL in Prostate Cancer: Lecture & Discussion- Matthew Rettig